Personalis, Inc. provided earnings guidance for the full year of 2022. For the year, the company's total company revenue is expected to be in the range of $62.0 million to $67.0 million; Revenue from biopharma and all other customers, excluding the VA MVP, is expected to be in the range of $55.0 million to $60.0 million; and Net loss is expected to be in the range of $110.0 million to $115.0 million.